Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Last Hour:
Last 24 Hours:

Global Smart Insulin Pens Market 2016 Analysis and Forecast to 2022

Friday, October 7, 2016 1:50
% of readers think this story is Fact. Add your two cents.

(Before It's News)


According to researcher, the Global Smart Insulin Pens market is accounted for $XX million in 2016 and is expected to reach $XX million by 2022 growing at a CAGR of XX%. Rising diabetic population and advancements in insulin delivery technologies are the factors fueling the market. Also, increasing adoption of smartphones which has made treatment easy is other major factor fueling the market. However, high cost of pens compared to injections and availability of alternative treatments may hamper the market growth. North America accounted for the largest share followed by Europe owing to growing aging population, increased funding for patients by health insurance companies and technological advancements.

Request a sample report @


Some of the key players in Global Smart Insulin Pens market include Vigihealth, Novo Nordisk A/S, Eli Lilly And Company, Jiangsu Delfu Medical Device Co.,Ltd, Emperra Gmbh and Digital Medics Ptd Ltd. 

Fabrication Material Covered: 
• Plastic 
• Metal

Technologies Covered: 
• Jet Injectors 
• Bluetooth 
• Spring Loaded

End Users Covered: 
• Retail Pharmacies 
• E-commerce 
• Hospital Pharmacies 
• Drugstores

Products Covered: 
• Accessories 
o Pen Needles 
o Timesulin Pen Cap 
o Insulin Cartridge 
• Prefilled/ Disposable Insulin Pens 
• Reusable/ Durable Insulin Pens

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

Buy this report @


1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Stake Holders 
2.3 Research Scope 
2.4 Research Methodology 
2.4.1 Data Mining 
2.4.2 Data Analysis 
2.4.3 Data Validation 
2.4.4 Research Approach 
2.5 Research Sources 
2.5.1 Primary Research Sources 
2.5.2 Secondary Research Sources 
2.5.3 Assumptions 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 
3.6 Technology Analysis 
3.7 Enduser Analysis 
3.8 Product Analysis 
3.9 Emerging Markets 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Smart Insulin Pens Market, By Fabrication Material 
5.1 Introduction 
5.2 Plastic 
5.3 Metal 

6 Global Smart Insulin Pens Market, By Technology 
6.1 Introduction 
6.2 Jet Injectors 
6.3 Bluetooth 
6.4 Spring loaded 

7 Global Smart Insulin Pens Market, By End User 
7.1 Introduction 
7.2 Retail Pharmacies 
7.3 E-commerce 
7.4 Hospital Pharmacies 
7.5 Drugstores 

8 Global Smart Insulin Pens Market, By Product 
8.1 Introduction 
8.2 Accessories 
8.2.1 Pen Needles 
8.2.2 Timesulin Pen Cap 
8.2.3 Insulin Cartridge 
8.3 Prefilled/ Disposable Insulin Pens 
8.4 Reusable/ Durable Insulin Pens 

9 Global Smart Insulin Pens Market, By Region 
9.1 North America 
9.1.1 US 
9.1.2 Canada 
9.1.3 Mexico 
9.2 Europe 
9.2.1 Germany 
9.2.2 France 
9.2.3 Italy 
9.2.4 UK 
9.2.5 Spain 
9.2.6 Rest of Europe 
9.3 Asia Pacific 
9.3.1 Japan 
9.3.2 China 
9.3.3 India 
9.3.4 Australia 
9.3.5 New Zealand 
9.3.6 Rest of Asia Pacific 
9.4 Rest of the World 
9.4.1 Middle East 
9.4.2 Brazil 
9.4.3 Argentina 
9.4.4 South Africa 
9.4.5 Egypt 

10 Key Developments 
10.1 Agreements, Partnerships, Collaborations and Joint Ventures 
10.2 Acquisitions & Mergers 
10.3 New Product Launch 
10.4 Expansions 
10.5 Other Key Strategies 

11 Company Profiling 
11.1 Vigihealth 
11.2 Novo Nordisk A/S 
11.3 Eli Lilly And Company 
11.4 Jiangsu Delfu Medical Device Co.,Ltd 
11.5 Emperra Gmbh 
11.6 Digital Medics Ptd Ltd 

Complete report details @


Contact US:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)           

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.